Sg Americas Securities, LLC Soleno Therapeutics Inc Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021
SELL
$0.8 - $1.12 $239,259 - $334,962
-299,074 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$0.97 - $1.32 $290,101 - $394,777
299,074 New
299,074 $341,000
Q3 2020

Nov 09, 2020
SELL
$1.71 - $2.51 $30,773 - $45,169
-17,996 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$1.77 - $4.23 $31,852 - $76,123
17,996 New
17,996 $40,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $362M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email